Assembly Bill 747 aims to regulate the sale of hemp-derived cannabinoid products in Wisconsin by establishing specific definitions, requirements, and restrictions. The bill modifies the current definition of hemp to include hemp-derived cannabinoid products and specifies that the qualifying criteria for hemp must be tested using high-performance liquid chromatography, gas chromatography-mass spectrometry, or other reliable methods. It introduces a new definition for hemp-derived cannabinoids and products, which includes various forms of THC, while excluding certain products like prescription drugs approved by the FDA.

The bill imposes strict regulations on the sale of hemp-derived cannabinoid products, particularly concerning age restrictions, labeling, and testing requirements. It prohibits the sale of these products to individuals under 21 years of age and requires sellers to verify the age of purchasers. Additionally, manufacturers must submit product samples for testing by accredited laboratories to ensure compliance with labeling claims and safety standards. The products must also be labeled with detailed information, including cannabinoid content and manufacturer details, and must be packaged in a child-resistant manner. The bill further clarifies that existing laws regarding hemp-related violations do not apply to the enforcement of these new provisions.

Statutes affected:
Bill Text: 94.55(1), 94.55